Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(2-Chloroethyl)piperidine → 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-4-(2-piperidin-1-yl-ethyl)-[1,4]diazepan-5-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(2-Chloroethyl)piperidine | HCID 74827 | — |
| 반응물 | 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-[1,4]diazepan-5-one | HCID 62044921 | — |
| 생성물 | 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-4-(2-piperidin-1-yl-ethyl)-[1,4]diazepan-5-one | HCID 68432387 | — |
반응 단계
In analogy to the procedure described in intermediate 4A, 1-[(E)-3-(3,4-dichloro-phenyl)-acryloyl]-[1,4]diazepan-5-one (intermediate 1A) and 1-(2-chloro-ethyl)-piperidine gave the title compound as white solid. MS: 424.1 (MH+, 2Cl).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07632829B2 |
| 출처 데이터셋 | uspto-grants-2009_12 |
| ORD ID | ord-2af552448bab4402adb04717ac842f6b |
| 출처 메모 | uspto-grants-2009_12 |